COVID-19感染合并急性脑血管事件的特征与结局
该回顾性观察研究纳入2020年3月1日至4月30日纽约某大型医疗系统连续收治的277例急性脑血管事件患者,其中105例(38.0%)COVID-19阳性。COVID-19阳性患者隐源性卒中比例更高(51.8%对22.3%,P<0.0001),病变更常位于颞叶、顶叶、枕叶及小脑,住院结局更差,院内死亡率为33%对12.9%(P<0.0001)。
要点
- COVID-19阳性卒中患者隐源性病因比例显著高于阴性患者(51.8%对22.3%)。
- COVID-19阳性患者缺血性卒中更常见于颞叶、顶叶、枕叶及小脑。
- COVID-19阳性患者住院时间更长、ICU需求更高、神经功能恶化及院内死亡更多。
核心结论
- COVID-19阳性卒中患者更常见隐源性病因和脑叶部位梗死,且住院结局更差。
研究设计与样本
- 纽约某大型医疗系统回顾性观察研究,连续纳入2020年3月1日至4月30日收治的277例急性脑血管事件患者,按COVID-19状态分层分析。
主要发现
- 105例(38.0%)患者COVID-19阳性;阳性患者隐源性卒中比例为51.8%,阴性患者为22.3%(P<0.0001)。
- 阳性患者缺血性卒中更多累及颞叶(P=0.02)、顶叶(P=0.002)、枕叶(P=0.002)和小脑(P=0.028)。
- 阳性患者凝血指标轻度升高:凝血酶原时间15.4±3.6秒,部分凝血活酶时间38.6±24.5秒,国际标准化比值1.4±1.3。
- 阳性患者住院时间更长(P<0.0001)、需ICU比例更高(P=0.017)、住院期间神经功能恶化更多(P<0.0001)。
- 院内死亡率为33%对12.9%(P<0.0001),阳性患者更高。
临床怎么用
- 对COVID-19患者出现急性神经功能缺损应警惕隐源性及多脑叶分布的卒中,并关注凝血指标。
- COVID-19合并卒中患者病情更重,应加强重症监护与神经功能监测。
局限性
- 回顾性观察设计,单一大城市医疗系统数据,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) has been associated with an increased incidence of thrombotic events, including stroke. However, characteristics and outcomes of COVID-19 patients with stroke are not well known. METHODS: We conducted a retrospective observational study of risk factors, stroke characteristics, and short-term outcomes in a large health system in New York City. We included consecutively admitted patients with acute cerebrovascular events from March 1, 2020 through April 30, 2020. Data were stratified by COVID-19 status, and demographic variables, medical comorbidities, stroke characteristics, imaging results, and in-hospital outcomes were examined. Among COVID-19-positive patients, we also summarized laboratory test results. RESULTS: Of 277 patients with stroke, 105 (38.0%) were COVID-19-positive. Compared with COVID-19-negative patients, COVID-19-positive patients were more likely to have a cryptogenic (51.8% versus 22.3%, P<0.0001) stroke cause and were more likely to suffer ischemic stroke in the temporal (P=0.02), parietal (P=0.002), occipital (P=0.002), and cerebellar (P=0.028) regions. In COVID-19-positive patients, mean coagulation markers were slightly elevated (prothrombin time 15.4±3.6 seconds, partial thromboplastin time 38.6±24.5 seconds, and international normalized ratio 1.4±1.3). Outcomes were worse among COVID-19-positive patients, including longer length of stay (P<0.0001), greater percentage requiring intensive care unit care (P=0.017), and greater rate of neurological worsening during admission (P<0.0001); additionally, more COVID-19-positive patients suffered in-hospital death (33% versus 12.9%, P<0.0001). CONCLUSIONS: Baseline characteristics in patients with stroke were similar comparing those with and without COVID-19. However, COVID-19-positive patients were more likely to experience stroke in a lobar location, more commonly had a cryptogenic cause, and had worse outcomes.
引用
- Dhamoon MS, Thaler A, Gururangan K, et al. Acute Cerebrovascular Events With COVID-19 Infection. Stroke. 2020. PMID: 33280551. doi:10.1161/STROKEAHA.120.031668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。